Abivax S.A. (ABVX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$87.83
+1.54%
Mkt Cap $7.19B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $1.80M | $509.43K | -71.75% | -$1.07 | -$1.22 | -13.62% |
| Q3 2025 Sep 8, 2025 | $1.39M | $2.37M | +70.56% | -$0.90 | -$0.86 | +4.44% |
| Q1 2025 Mar 24, 2025 | $3.11M | $7.66M | +146.20% | -$0.68 | -$1.55 | -128.04% |
| Q4 2024 Nov 7, 2024 | $3.41M | $3.65M | +7.05% | -$1.28 | -$0.70 | +45.50% |
| Q2 2024 Apr 2, 2024 | $2.47M | $2.56M | +3.70% | -$0.91 | -$1.94 | -112.73% |
| Q2 2023 Jun 30, 2023 | — | $2.45M | — | — | -$1.58 | — |
| Q4 2022 Dec 31, 2022 | — | $2.42M | — | -$1.93 | -$1.95 | -0.81% |
| Q2 2022 Jun 30, 2022 | — | $2.33M | — | — | -$1.84 | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$1.68 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$1.34 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$1.90 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$1.42 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$1.53 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$1.57 | — |
| Q4 2018 Dec 31, 2018 | — | $385.95K | — | — | -$0.98 | — |
| Q2 2018 Jun 30, 2018 | — | $571.13K | — | — | -$0.84 | — |
| Q4 2017 Dec 31, 2017 | — | $413.00K | — | — | -$0.66 | — |
| Q2 2017 Jun 30, 2017 | — | $4.56K | — | — | -$0.65 | — |
| Q4 2016 Dec 31, 2016 | — | $14.69K | — | — | -$0.64 | — |
| Q2 2016 Jun 30, 2016 | — | $152.27K | — | — | -$0.95 | — |
| Q4 2015 Dec 31, 2015 | — | -$89.48K | — | — | -$0.97 | — |
| Q2 2015 Jun 30, 2015 | — | $343.73K | — | — | -$0.83 | — |
| Q4 2014 Dec 31, 2014 | — | $245.33K | — | — | -$0.62 | — |
| Q2 2014 Jun 30, 2014 | — | — | — | — | -$0.10 | — |